April 26, 1990 |
The Securities and Exchange Commission is investigating trading in the stock of ICN Biomedicals during 1988, the company confirmed Wednesday. The Costa Mesa-based chemical research company said it received a request from the SEC in January asking that it voluntarily provide information about trading in the company's stock. The inquiry also involves the trading of stock by an undisclosed company or individual in companies considering a merger or acquisition of ICN Biomedicals.
May 16, 1990
ICN Biomedicals, a Costa Mesa supplier of biotechnology research and medical diagnostic products, said Tuesday that its price for acquiring Flow Laboratories has been reduced from $41.5 million to $37.6 million. Flow Laboratories is a supplier of life sciences research products that was acquired by ICN in November, 1989. The adjustment in the purchase price was based on a financial review of Flow Laboratories by an independent auditing firm, said Jack Sholl, an ICN spokesman.